COVID-19 in the heart and the lungs: could we "Notch" the inflammatory storm?

Paola Rizzo1,2, Francesco Vieceli Dalla Sega3, Francesca Fortini3

  • 1Department of Morphology, Surgery and Experimental Medicine and Laboratory for Technologies of Advanced Therapies (LTTA), University of Ferrara, Ferrara, Italy. rzzpla@unife.it.

Insights

This study explores targeting Notch signaling to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and mitigate COVID-19-related heart and lung complications. Modulating this pathway may offer a novel therapeutic strategy for viral infections and associated cardiovascular disease.

Area of Science:

  • Cardiovascular Biology
  • Virology
  • Molecular Signaling

Background:

  • Coronavirus disease (COVID-19), caused by SARS-CoV-2, has led to a global health crisis.
  • Cardiac complications like myocarditis and heart failure are observed in COVID-19 patients, indicating a link between SARS-CoV-2 infection and cardiovascular disease.
  • Notch signaling is crucial for cardiovascular function and plays a role in viral infection pathways.

Discussion:

  • This report investigates the potential of targeting Notch signaling as a therapeutic strategy against SARS-CoV-2.
  • Interfering with Notch signaling could prevent viral entry or replication.
  • Modulating Notch signaling may also address COVID-19-associated cardiac and pulmonary pathologies.

Key Insights:

  • A potential therapeutic target for COVID-19 and its cardiac sequelae is identified.
  • The role of Notch signaling in both cardiovascular health and viral pathogenesis is highlighted.
  • This research opens avenues for novel treatment strategies.

Outlook:

  • Further research is needed to validate Notch signaling as a therapeutic target for COVID-19.
  • Preclinical and clinical studies are required to assess the safety and efficacy of Notch pathway modulators.
  • This approach could lead to new treatments for viral myocarditis and other cardiovascular complications.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
280
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.4K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.1K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
337
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
279